Reference Hub1
Analyzing the Effectiveness of Pharmaceutical Marketing Using Business Intelligence Methods

Analyzing the Effectiveness of Pharmaceutical Marketing Using Business Intelligence Methods

Elizabeth H. Ricks, John Yi
Copyright: © 2012 |Volume: 3 |Issue: 3 |Pages: 15
ISSN: 1947-3591|EISSN: 1947-3605|EISBN13: 9781466611092|DOI: 10.4018/jbir.2012070101
Cite Article Cite Article

MLA

Ricks, Elizabeth H., and John Yi. "Analyzing the Effectiveness of Pharmaceutical Marketing Using Business Intelligence Methods." IJBIR vol.3, no.3 2012: pp.1-15. http://doi.org/10.4018/jbir.2012070101

APA

Ricks, E. H. & Yi, J. (2012). Analyzing the Effectiveness of Pharmaceutical Marketing Using Business Intelligence Methods. International Journal of Business Intelligence Research (IJBIR), 3(3), 1-15. http://doi.org/10.4018/jbir.2012070101

Chicago

Ricks, Elizabeth H., and John Yi. "Analyzing the Effectiveness of Pharmaceutical Marketing Using Business Intelligence Methods," International Journal of Business Intelligence Research (IJBIR) 3, no.3: 1-15. http://doi.org/10.4018/jbir.2012070101

Export Reference

Mendeley
Favorite Full-Issue Download

Abstract

Pharmaceutical companies have traditionally marketed their products through a combination of several channels: sales details to physicians, direct-to-consumer advertising, professional medical journal advertising, sponsorship of meetings and events and e-promotion. With an impending patent cliff and subsequent loss in revenue, the industry must depend on, among many factors, recently launched products to offset the revenue loss. Coupled with increased generic competition, companies must evaluate the return on investment of their marketing dollars. This paper analyzes the effectiveness of traditional marketing methods, both industry-wide and for recently launched products, using the latest Business Intelligent methods. The dataset used in this paper is a sample of prescription, promotional, competitive, and product data from SDI Health. The analysis in this paper reveals that traditional marketing methods have a decreasing level of impact with the number of prescriptions dispensed, and describes new potential channels for marketing, as well as collecting and analyzing data to aid the industry improve its resource utilization.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.